We are the trusted partners in clinical trial execution. With our proven clinical trial expertise, we conduct high-quality clinical trials with regulatory alignment, precision and care. Clinical trials are our core business and top priority—and we ensure they are always supported with dedicated, expert resources.
In all our clinical research, we adhere to Good Clinical Practice (GCP), an international quality standard for designing, conducting, recording and reporting clinical trials.
We conduct phase II, III and IV studies in the prevention and treatment of chronic diseases. Our three focus areas—obesity, diabetes and cardiovascular diseases—are at the forefront of clinical research and closely interrelated.
We also conduct research in other therapeutic areas, including pain, vaccines, memory disorders, nephrology, and dyslipidemia.
Obesity is a growing health concern that involves complex factors beyond just energy intake and expenditure. Clinical trials evaluate the safety and efficacy of new and existing weight-loss medication and different lifestyle approaches to promote weight loss and management, prevent and treat comorbidities and tackle the reasons behind obesity.
Clinical trials on diabetes aim to discover new and improved ways to prevent, detect and treat a disease that is affecting a growing number of people globally. Diabetes research plays a major role in our efforts to tackle this serious global health concern that also has significant economic repercussions.
Cardiovascular diseases are a leading cause of death worldwide posing a major challenge to public health systems. Given the obvious need for medical advances, they are among the most extensively studied fields in clinical trials. The field also has a long history of significant scientific breakthroughs that have shaped modern medicine.
Participating in a clinical trial means investing in your own health while contributing to medical advances.
We are currently recruiting participants for the following trials.